These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 10683287)

  • 61. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions.
    Chang JW; Wachtel SR; Young D; Kang UJ
    Neuroscience; 1999 Jan; 88(2):617-28. PubMed ID: 10197780
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
    Sarre S; Lanza M; Makovec F; Artusi R; Caselli G; Michotte Y
    Eur J Pharmacol; 2008 Apr; 584(2-3):297-305. PubMed ID: 18342306
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
    Visanji NP; Fox SH; Johnston T; Reyes G; Millan MJ; Brotchie JM
    Neurobiol Dis; 2009 Aug; 35(2):184-92. PubMed ID: 19118628
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats.
    Boules M; Warrington L; Fauq A; McCormick D; Richelson E
    Eur J Pharmacol; 2001 Oct; 428(2):227-33. PubMed ID: 11675040
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
    Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
    Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An autoradiographic study on the pathogenesis of levodopa-induced dyskinesia: regulation of dopamine transporter by levodopa in a rat model of Parkinson's disease.
    Cai XY; Kong XM; Fang Q; Ning P; Xu YJ; Zhang B; Xue SR
    Neurodegener Dis; 2012; 9(1):11-7. PubMed ID: 21876323
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Extent of pre-operative L-DOPA-induced dyskinesia predicts the severity of graft-induced dyskinesia after fetal dopamine cell transplantation.
    García J; Carlsson T; Döbrössy M; Nikkhah G; Winkler C
    Exp Neurol; 2011 Dec; 232(2):270-9. PubMed ID: 21946270
    [TBL] [Abstract][Full Text] [Related]  

  • 68. L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases.
    Napolitano M; Picconi B; Centonze D; Bernardi G; Calabresi P; Gulino A
    Neurosci Lett; 2006 May; 398(3):211-4. PubMed ID: 16529858
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.
    Ohlin KE; Sebastianutto I; Adkins CE; Lundblad C; Lockman PR; Cenci MA
    Neuroimage; 2012 May; 61(1):228-39. PubMed ID: 22406356
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of repeated methyl levodopa administration on apomorphine sensitivity of rotational behavior and striatal Fos expression of rats with unilateral 6-OHDA lesions.
    Kashihara K; Manabe Y; Shiro Y; Warita H; Abe K
    Neurosci Res; 2000 Nov; 38(3):273-9. PubMed ID: 11070194
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.
    Haghdoost-Yazdi H; Faraji A; Fraidouni N; Movahedi M; Hadibeygi E; Vaezi F
    Behav Brain Res; 2011 Sep; 223(1):70-4. PubMed ID: 21540059
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Computerized rotometer apparatus for recording circling behavior.
    Etemadzadeh E; Koskinen L; Kaakkola S
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):399-407. PubMed ID: 2501597
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.
    Thornburg JE; Moore KE
    J Pharmacol Exp Ther; 1975 Jan; 192(1):42-9. PubMed ID: 1168250
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of repeated administration of l-DOPA and apomorphine on circling behavior and striatal dopamine formation.
    Brannan T; Prikhojan A; Yahr MD
    Brain Res; 1998 Feb; 784(1-2):148-53. PubMed ID: 9518585
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Fox SH; Moser B; Brotchie JM
    Exp Neurol; 1998 May; 151(1):35-49. PubMed ID: 9582253
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6-OHDA-lesioned rats.
    Papathanou M; Rose S; McCreary A; Jenner P
    Eur J Neurosci; 2011 Jun; 33(12):2247-54. PubMed ID: 21615558
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CART modulates the effects of levodopa in rat model of Parkinson's disease.
    Upadhya MA; Shelkar GP; Subhedar NK; Kokare DM
    Behav Brain Res; 2016 Mar; 301():262-72. PubMed ID: 26771081
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased excitability in serotonin neurons in the dorsal raphe nucleus in the 6-OHDA mouse model of Parkinson's disease.
    Prinz A; Selesnew LM; Liss B; Roeper J; Carlsson T
    Exp Neurol; 2013 Oct; 248():236-45. PubMed ID: 23810738
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Circling behavior in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 1. Effects of apomorphine and L-dopa.
    Saligaut C; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):219-24. PubMed ID: 3110513
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modification of levodopa responses by deprenyl (selegiline): an electrophysiological and behavioral study in the rat relevant to Parkinson's disease.
    Mercuri NB; Scarponi M; Federici M; Bonci A; Siniscalchi A; Bernardi G
    Ann Neurol; 1998 May; 43(5):613-7. PubMed ID: 9585355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.